Infectious Diseases 1511 - Infectious Disease Alert - Nov 01, 2011

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Hal B. Jenson, MD, FAAP
Dean, Western Michigan University School of Medicine
Kalamazoo, Michigan

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine

Joseph F. John, MD, FACP, FIDSA, FSHEA
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina, Charleston

Subjects:

  • Otoscopic Signs of Otitis Media
  • Necrotizing Pneumococcal Pneumonia in Children due to Streptococcus pneumoniae
  • Effect of an Oxazolidinone and Clindamycin on Staphylococcus aureus Virulence Factors
  • Movies and Politicians: Which Are Reality-based?
  • Clostridium difficile BI: From Canada to the Second City
  • HIV-1 Protein, Nef, Contributes to Insulin Resistance
  • Moxifloxacin for Odontogenic Infection
  • Intravenous Immune Globulin for Neonatal Sepsis
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, Associate Editors Hal B. Jenson, MD, FAAP, and Joseph F. John, MD, FACP, FIDSA, FSHEA report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, is a speaker for Cubist Pharmaceuticals and GSK, and is a consultant for Siemens Diagnostics.

Copyright 2011 AHC Media. All rights reserved.